Efficacy of levosimendan in Takotsubo-related cardiogenic shock.
Antonini
M
M
Stazi
G V
GV
Cirasa
M T
MT
Garotto
G
G
Frustaci
A
A
D000368:Aged; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006835:Hydrazones / Q000627:therapeutic use*; D011724:Pyridazines / Q000627:therapeutic use*; D012121:Respiration, Artificial; D012770:Shock, Cardiogenic / Q000188:drug therapy* / Q000209:etiology; D000077464:Simendan; D054549:Takotsubo Cardiomyopathy / Q000150:complications* / Q000175:diagnosis
D002316:Cardiotonic Agents; D006835:Hydrazones; D011724:Pyridazines; D000077464:Simendan